Navigation Links
‘Aricept’ drug gives an Alzheimer’s patient reason to smle

Close on the heels of a petition from charities and campaign groups to extend the reach of Alzheimer’s drugs, the NHS drug regulator has disallowed// the use of the drug during the preliminary stages of the disease.

When John, aged 77, showed initial symptoms of Alzheimer’s, doctors had recommended the benefit of one of the controversial drugs, ‘Aricept’ in retarding the advancement of the disease. After 2 years of consuming the drug, which had improved John’s life remarkably, Doctors suggested that John participate in the clinical trial of a new drug that held promise for reversing the downslide in Alzheimer’s patients.

During the trial, the drug ‘Aricept’ was replaced by the new drug. John’s wife, Valerie, could visibly perceive the rapid decline in John’s condition with the new drug. Valerie perceivably distraught said,” In just a couple of weeks after coming off the drug, he absolutely fell to pieces. He had been able to do most things; make a cup of tea, dress himself. But he was totally dependent within the fortnight. He couldn't dress himself; he started to wander and to fall. He didn't even know where our bedroom was."

Presently the couple have withdrawn from the clinical trial of the new drug and reverted to the previous treatment with ‘Aricept.’ The couple vouch that this drug had done wonders to improve their quality of life.

The National Institute for health and Clinical Excellence reiterated, the drugs are not to be used for management of early stages of the disease.


Page: 1

Related medicine news :

1. Microchip gives blind a chance of sight
2. Microchip gives blind a chance of sight
3. Combined scan gives exact cancer diagnosis
4. Tennis gives protection against heart disease lifelong
5. Camera gives hope for detection of breast cancer
6. Pancreas transplant gives hope to type 2 diabetes
7. FDA gives “black box warning” against three asthma drus
8. Trust in Doctor gives better cure
9. Wonder drug Dasatinib gives hopes to leukemia patients
10. 5 Year Old Paralyzed Victim Forgives 50 Year Old Man Who Shot Her
11. LA County gives Approval for Reform Plan for King-Drew Medical Center
Post Your Comments:

(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... National recruitment firm ... life sciences executive with extensive sequencing and genomics experience, as Vice President of North ... Ms. Hill will be responsible for leading the sales team in the commercialization of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: